{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:56:23Z","timestamp":1789710983435,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["EDCTP Senior Fellowship TA 2009.40200.020"],"award-info":[{"award-number":["EDCTP Senior Fellowship TA 2009.40200.020"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003024","name":"International Society for Infectious Diseases","doi-asserted-by":"publisher","award":["077166\/Z\/05\/Z"],"award-info":[{"award-number":["077166\/Z\/05\/Z"]}],"id":[{"id":"10.13039\/100003024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust of Great Britain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2924-5","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T18:24:31Z","timestamp":1514399071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-1968","authenticated-orcid":false,"given":"Pauline","family":"Byakika-Kibwika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Achan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Lamorde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Karera-Gonahasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes N.","family":"Kiragga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Mayanja-Kizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Kiwanuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Nsobya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrose O.","family":"Talisuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepta","family":"Merry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"2924_CR1","volume-title":"World malaria report","author":"WHO","year":"2015","unstructured":"WHO: World malaria report. 2015."},{"key":"2924_CR2","volume-title":"Guidelines for the treatment of malaria. Third edition","author":"WHO","year":"2015","unstructured":"WHO: Guidelines for the treatment of malaria. Third edition. 2015."},{"issue":"9753","key":"2924_CR3","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","volume":"376","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647\u201357.","journal-title":"Lancet"},{"issue":"5","key":"2924_CR4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3855\/jidc.3813","volume":"8","author":"TM Abdallah","year":"2014","unstructured":"Abdallah TM, Elmardi KA, Elhassan AH, Omer MB, Elhag MS, Desogi MA, Siddig MF, Adam I. Comparison of artesunate and quinine in the treatment of severe plasmodium falciparum malaria at Kassala hospital, Sudan. J Infect Dev Ctries. 2014;8(5):611\u20135.","journal-title":"J Infect Dev Ctries"},{"issue":"9487","key":"2924_CR5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","volume":"366","author":"A Dondorp","year":"2005","unstructured":"Dondorp A, Nosten F, Stepniewska K, Day N, White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366(9487):717\u201325.","journal-title":"Lancet"},{"key":"2924_CR6","first-page":"CD005967","volume":"6","author":"D Sinclair","year":"2012","unstructured":"Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012;6:CD005967.","journal-title":"Cochrane Database Syst Rev"},{"key":"2924_CR7","first-page":"CD005967","volume":"3","author":"D Sinclair","year":"2011","unstructured":"Sinclair D, Donegan S, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2011;3:CD005967.","journal-title":"Cochrane Database Syst Rev"},{"key":"2924_CR8","volume-title":"Report says Uganda health workers using abolished drug","author":"Week EAB","year":"2016","unstructured":"Week EAB: Report says Uganda health workers using abolished drug. 2016."},{"key":"2924_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0065-308X(02)52013-3","volume":"52","author":"RW Snow","year":"2002","unstructured":"Snow RW, Marsh K. The consequences of reducing transmission of plasmodium falciparum in Africa. Adv Parasitol. 2002;52:235\u201364.","journal-title":"Adv Parasitol"},{"issue":"1\u20133","key":"2924_CR10","first-page":"241","volume":"41","author":"K Marsh","year":"1999","unstructured":"Marsh K, Snow RW. Malaria transmission and morbidity. Parassitologia. 1999;41(1\u20133):241\u20136.","journal-title":"Parassitologia"},{"issue":"32","key":"2924_CR11","first-page":"1475","volume":"13","author":"MK Muhindo","year":"2014","unstructured":"Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, Arinaitwe E, Tappero JW, Kaharuza F, Kamya MR, et al. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated plasmodium falciparum malaria. Malar J. 2014;13(32):1475\u20132875.","journal-title":"Malar J"},{"issue":"6","key":"2924_CR12","doi-asserted-by":"crossref","first-page":"0002390","DOI":"10.1371\/journal.pone.0002390","volume":"3","author":"A Yeka","year":"2008","unstructured":"Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One. 2008;3(6):0002390.","journal-title":"PLoS One"},{"issue":"6","key":"2924_CR13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0035-9203(99)90073-1","volume":"93","author":"JA Kurtzhals","year":"1999","unstructured":"Kurtzhals JA, Addae MM, Akanmori BD, Dunyo S, Koram KA, Appawu MA, Nkrumah FK, Hviid L. Anaemia caused by asymptomatic plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg. 1999;93(6):623\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"2924_CR14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4269\/ajtmh.14-0312","volume":"92","author":"MR Kamya","year":"2015","unstructured":"Kamya MR, Arinaitwe E, Wanzira H, Katureebe A, Barusya C, Kigozi SP, Kilama M, Tatem AJ, Rosenthal PJ, Drakeley C, et al. Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control. Am J Trop Med Hyg. 2015;92(5):903\u201312.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"2924_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52(6):565\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"2924_CR16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4269\/ajtmh.1998.59.726","volume":"59","author":"J Zwetyenga","year":"1998","unstructured":"Zwetyenga J, Rogier C, Tall A, Fontenille D, Snounou G, Trape JF, Mercereau-Puijalon O. No influence of age on infection complexity and allelic distribution in plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg. 1998;59(5):726\u201335.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2924_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0166-6851(91)90135-S","volume":"49","author":"MB Borre","year":"1991","unstructured":"Borre MB, Dziegiel M, Hogh B, Petersen E, Rieneck K, Riley E, Meis JF, Aikawa M, Nakamura K, Harada M, et al. Primary structure and localization of a conserved immunogenic plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol. 1991;49(1):119\u201331.","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"2924_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2003.68.133","volume":"68","author":"A Cattamanchi","year":"2003","unstructured":"Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg. 2003;68(2):133\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2924_CR19","first-page":"206","volume":"9","author":"P Byakika-Kibwika","year":"2009","unstructured":"Byakika-Kibwika P, Ndeezi G, Kamya MR. Health care related factors associated with severe malaria in children in Kampala, Uganda. Afr Health Sci. 2009;9(3):206\u201310.","journal-title":"Afr Health Sci"},{"issue":"1","key":"2924_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1371\/journal.pctr.0010007","volume":"1","author":"H Bukirwa","year":"2006","unstructured":"Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, Rwakimari JB, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, et al. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS clinical trials. 2006;1(1):19.","journal-title":"PLoS clinical trials"},{"issue":"10","key":"2924_CR21","first-page":"19","volume":"263674","author":"W Akpaloo","year":"2014","unstructured":"Akpaloo W, Purssell E. Does the use of Dihydroartemisinin-Piperaquine in treating patients with uncomplicated falciparum malaria reduce the risk for recurrent new falciparum infection more than Artemether-Lumefantrine? Malar Res Treat. 2014;263674(10):19.","journal-title":"Malar Res Treat"},{"issue":"5","key":"2924_CR22","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.pctr.0020020","volume":"2","author":"MR Kamya","year":"2007","unstructured":"Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS clinical trials. 2007;2(5):e20.","journal-title":"PLoS clinical trials"},{"issue":"1","key":"2924_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-3156.2007.01977.x","volume":"13","author":"P Olliaro","year":"2008","unstructured":"Olliaro P, Pinoges L, Checchi F, Vaillant M, Guthmann JP. Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Tropical Med Int Health. 2008;13(1):83\u201390.","journal-title":"Tropical Med Int Health"},{"key":"2924_CR24","volume-title":"WHO weekly epidemiological record","author":"WHO","year":"2016","unstructured":"WHO: WHO weekly epidemiological record. 2016."},{"issue":"1","key":"2924_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22(1):13\u201336.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2924_CR26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.actatropica.2011.03.004","volume":"121","author":"A Yeka","year":"2012","unstructured":"Yeka A, Gasasira A, Mpimbaza A, Achan J, Nankabirwa J, Nsobya S, Staedke SG, Donnelly MJ, Wabwire-Mangen F, Talisuna A, et al. Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts. Acta Trop. 2012;121(3):184\u201395.","journal-title":"Acta Trop"},{"issue":"3","key":"2924_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(11)70320-6","volume":"12","author":"K Phiri","year":"2012","unstructured":"Phiri K, Esan M, van Hensbroek MB, Khairallah C, Faragher B, ter Kuile FO. Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial. Lancet Infect Dis. 2012;12(3):191\u2013200.","journal-title":"Lancet Infect Dis"},{"issue":"450","key":"2924_CR28","first-page":"015","volume":"14","author":"JR Matangila","year":"2015","unstructured":"Matangila JR, Mitashi P, Inocencio da Luz RA, Lutumba PT, Van Geertruyden JP. Efficacy and safety of intermittent preventive treatment for malaria in schoolchildren: a systematic review. Malar J. 2015;14(450):015\u20130988.","journal-title":"Malar J"},{"issue":"1","key":"2924_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-3156.2005.01518.x","volume":"11","author":"R Idro","year":"2006","unstructured":"Idro R, Aloyo J, Mayende L, Bitarakwate E, John CC, Kivumbi GW. Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda. Tropical Med Int Health. 2006;11(1):115\u201324.","journal-title":"Tropical Med Int Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2924-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T15:39:02Z","timestamp":1570549142000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2924-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2924-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"794"}}